Varicella zoster virus encephalitis: a potentially serious complication during treatment with vedolizumab.
Rev Esp Enferm Dig
; 115(5): 271-272, 2023 05.
Article
em En
| MEDLINE
| ID: mdl-36148676
ABSTRACT
Vedolizumab is a monoclonal antibody that has demonstrated efficacy and a good safety profile in patients with inflammatory bowel disease. Varicella zoster virus encephalitis is a potentially serious complication not previously described with its use, highlighting the importance of vaccination, as well as early diagnosis and treatment of infections in this type of patients.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Varicela
/
Encefalite por Varicela Zoster
/
Herpes Zoster
Tipo de estudo:
Screening_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article